Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytotoxic drug extravasation

K Fenchel1, M Karthaus

  • 1Abteilung Hämatologie und internistische Onkologie, Justus-Liebig Universität, Giessen. Klaus.fenchel@innere.med.uni-giessen.de

Antibiotics and Chemotherapy
|June 30, 2000
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial.

ESMO open·2024
Same author

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

ESMO open·2023
Same author

Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.

BMC cancer·2022
Same author

Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.

ESMO open·2022
Same author

Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
Same journal

Diarrhea and constipation.

Antibiotics and chemotherapy·2000
Same journal

Treatment of chemotherapy-induced emesis.

Antibiotics and chemotherapy·2000
Same journal

Quality of life assessment--problems and goals.

Antibiotics and chemotherapy·2000
Same journal

Anticoagulant prophylaxis and therapy in patients with cancer.

Antibiotics and chemotherapy·2000
Same journal

Central venous catheter-related complications.

Antibiotics and chemotherapy·2000
Same journal

New strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis.

Antibiotics and chemotherapy·2000
See all related articles